Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Malignant Melanoma

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 29 articles:
HTML format

Single Articles


    June 2008
  1. GAMBAROTA G , Leenders W, Maass C, Wesseling P, et al
    Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI.
    Br J Cancer. 2008;98:1784-9.
    PubMed     Related articles    Abstract available


    May 2008
  2. GUGGENHEIM M , Dummer R, Jung FJ, Mihic-Probst D, et al
    The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma - a retrospective analysis of 392 cases.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available


    January 2008
  3. SHARMA R , Kacevska M, London R, Clarke SJ, et al
    Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies.
    Br J Cancer. 2008;98:91-7.
    PubMed     Related articles    Abstract available


    December 2007
  4. FRANCO-LIE I , Iversen T, Robsahm TE, Abdelnoor M, et al
    Birth weight and melanoma risk: a population-based case-control study.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    November 2007
  5. THIES A , Dautel P, Meyer A, Pfuller U, et al
    Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  6. MHAIDAT NM , Zhang XD, Allen J, Avery-Kiejda KA, et al
    Temozolomide induces senescence but not apoptosis in human melanoma cells.
    Br J Cancer. 2007;97:1225-33.
    PubMed     Related articles    Abstract available   Free Full Text


    October 2007
  7. ATZPODIEN J , Terfloth K, Fluck M, Reitz M, et al
    Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    June 2007
  8. PRITCHARD-JONES RO , Dunn DB, Qiu Y, Varey AH, et al
    Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  9. FOJTOVA M , Boudny V, Kovarik A, Lauerova L, et al
    Development of IFN-gamma resistance is associated with attenuation of SOCS genes induction and constitutive expression of SOCS 3 in melanoma cells.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  10. POLAK ME , Borthwick NJ, Gabriel FG, Johnson P, et al
    Mechanisms of local immunosuppression in cutaneous melanoma.
    Br J Cancer. 2007;96:1879-87.
    PubMed     Related articles    Abstract available


  11. MACKIE RM , Bray C, Vestey J, Doherty V, et al
    Melanoma incidence and mortality in Scotland 1979-2003.
    Br J Cancer. 2007;96:1772-7.
    PubMed     Related articles    Abstract available


  12. ALSTON RD , Rowan S, Eden TO, Moran A, et al
    Cancer incidence patterns by region and socioeconomic deprivation in teenagers and young adults in England.
    Br J Cancer. 2007;96:1760-6.
    PubMed     Related articles    Abstract available


    March 2007
  13. FEDER-MENGUS C , Ghosh S, Weber WP, Wyler S, et al
    Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    February 2007
  14. LICKLITER JD , Cox J, McCarron J, Martinez NR, et al
    Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.
    Br J Cancer. 2007;96:600-8.
    PubMed     Related articles    Abstract available


  15. FORGET MA , Turcotte S, Beauseigle D, Godin-Ethier J, et al
    The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types.
    Br J Cancer. 2007;96:646-53.
    PubMed     Related articles    Abstract available


  16. MOWBRAY M , Stockton DL, Doherty VR
    Changes in the site distribution of malignant melanoma in South East Scotland (1979-2002).
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available


    January 2007
  17. THIES A , Mauer S, Fodstad O, Schumacher U, et al
    Clinically proven markers of metastasis predict metastatic spread of human melanoma cells engrafted in scid mice.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  18. SMALLEY KS , Contractor R, Haass NK, Lee JT, et al
    Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels.
    Br J Cancer. 2007;.
    PubMed     Related articles    Abstract available


  19. KORBELIK M , Cooper PD
    Potentiation of photodynamic therapy of cancer by complement: the effect of gamma-inulin.
    Br J Cancer. 2007;96:67-72.
    PubMed     Related articles    Abstract available


    December 2006
  20. LARKIN JM , Hughes SA, Beirne DA, Patel PM, et al
    A Phase I/II study of lomustine and temozolomide in patients with cerebral metastases from malignant melanoma.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available


    September 2006
  21. MILLWARD MJ , House C, Bowtell D, Webster L, et al
    The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available


    August 2006
  22. GRAY-SCHOPFER VC , Cheong SC, Chong H, Chow J, et al
    Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available


  23. EISEN T , Ahmad T, Flaherty KT, Gore M, et al
    Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available


    July 2006
  24. GOTTLIEB DJ , Li YC, Lionello I, Tanzarella S, et al
    Generation of tumour-specific cytotoxic T-cell clones from histocompatibility leucocyte antigen-identical siblings of patients with melanoma.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available


    June 2006
  25. LU F , Dai DL, Martinka M, Ho V, et al
    Nuclear ING2 expression is reduced in human cutaneous melanomas.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available


  26. DOWNING A , Newton-Bishop JA, Forman D
    Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available


    May 2006
  27. STREIT S , Mestel DS, Schmidt M, Ullrich A, et al
    FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available


  28. FONTIJN D , Duyndam MC, van Berkel MP, Yuana Y, et al
    CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available


    April 2006
  29. LAU YS , Sabokbar A, Giele H, Cerundolo V, et al
    Malignant melanoma and bone resorption.
    Br J Cancer. 2006;.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: